TITLE

Response steps to an MH crisis

PUB. DATE
September 2008
SOURCE
Same-Day Surgery;Sep2008, Vol. 32 Issue 9, p96
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers important steps useful when the patient develops malignant hyperthermia (MH).
ACCESSION #
34357226

 

Related Articles

  • Hipertermia maligna: ¿cómo estar preparados? CORVETTO A., MARCIA; HEIDER M., ROSE; CAVALLIERI B., SILVANA // Revista Chilena de Cirugia;jun2013, Vol. 65 Issue 3, p279 

    Malignant hyperthermia is an autosomal dominant genetic disease that affects the skeletal muscle. Specifically corresponds to a hypermetabolic response against triggering agents such as halogenated gases and the muscle relaxant succinylcholine. Because MH is a potentially fatal disease and...

  • Malignant Hyperthermia during Desflurane - Succinylcholine Anesthesia for Neurosurgery: A case report. Baysal, Zeynep; Avci, Emel; Torun, Fuat; Cengiz, Mustafa; Çigdem, Ali; Togrul, Turhan; Nacar, Halil; Çakir, Ahmet // Internet Journal of Neurosurgery;2009, Vol. 5 Issue 2, p6 

    Desflurane has been known as a weak triggering anesthetic of malignant hyperthermia (MH). It may produce a delayed onset of symptoms. In addition the use of succinylcholine may aggravate occurrence of MH. The prolonged interval after exposure may occur more than 3 h after the induction of...

  • The Malignant Hyperthermia Syndrome. Greenfield, Saul; Bronsther, Burton; Abrams, Martin W.; Rosenberg, Henry // Clinical Pediatrics;Sep1977, Vol. 16 Issue 9, p808 

    Presents the case of a 12-year-old white boy with malignant hyperthermia syndrome. Medical history; Complication of anesthesia; Features of the rigid variety of the malignant hyperthermia syndrome; Association of the syndrome with recognizable musculoskeletal abnormalities; Treatment.

  • Malignant hyperthermia: a crisis response plan. Johns, Christopher D.; Staudt, Rebecca S.; Scholtis, Michael P.; Gavel, Theodore // OR Manager;Jun2012, Vol. 28 Issue 6, p18 

    The article presents information on hospital crisis management, with a focus on the appropriate medical response for patients with malignant hyperthermia (MH), a genetic skeletal muscle disorder incited by anesthesia drugs. Topics include the incidence of MH in U.S. hospitals; the mortality rate...

  • Ambulatory Anesthesia in Deficiency Glucose 6-phosphate dehydrogenase. Del Massa, Emilio C.; Federmann, Sidney // Internet Journal of Anesthesiology;2007, Vol. 11 Issue 2, p21 

    This report aimed at presenting a case of a Glucose 6-phosphate dehydrogenase (G6PD) deficient patient, undergoing ambulatory anesthesia with inhalatory anesthesia associated to caudal block. Case Report: Male patient, 2 years old, with G6PD deficiency diagnosed to the birth after jaundice for...

  • Spinal Anesthesia Management in Central Core Disease: A Case Report. Sarihasan, Binnur; Kelsaka, Ebru // Turkish Journal of Medical Sciences;2006, Vol. 36 Issue 6, p393 

    Central core disease is a rare neuromuscular disorder associated with leg weakness. It is a familial disease with autosomal dominant inheritance. Central core disease has been reported to be associated with malignant hyperthermia. A 25-year-old woman with central core disease was scheduled to be...

  • COMMENTARY. Wappler, Frank // British Journal of Sports Medicine;May2007, Vol. 41 Issue 5, p284 

    The author reflects on the link between malignant hyperthermia (MH) and exertional heat illness. He states that the study presents relevant aspects of MH and exertional heat illness. He suggests to develop guidelines for investigating patients with exertional heat illness specifically with...

  • Cyclic ADP-ribose induces a larger than normal calcium release in malignant hyperthermia-susceptible skeletal muscle fibers. López, J.R.; Cordovez, G.; Linares, N.; Allen, P.D. // Pflugers Archiv European Journal of Physiology;Jun2000, Vol. 440 Issue 2, p236 

    Malignant hyperthermia (MH) is associated with abnormal regulation of intracellular calcium in skeletal muscle fibers. Cyclic adenosine diphosphate-ribose (cADPR) is an endogenous metabolite of β-NAD+ that induces Ca2+ release from intracellular stores in many tissues. Microinjection of cADPR...

  • Calcium Homeostasis in Myogenic Differentiation Factor 1 (MyoD)-Transformed, Virally-Transduced, Skin-Derived Equine Myotubes. Fernandez-Fuente, Marta; Terracciano, Cesare M.; Martin-Duque, Pilar; Brown, Susan C.; Vassaux, Georges; Piercy, Richard J. // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Dysfunctional skeletal muscle calcium homeostasis plays a central role in the pathophysiology of several human and animal skeletal muscle disorders, in particular, genetic disorders associated with ryanodine receptor 1 (RYR1) mutations, such as malignant hyperthermia, central core disease,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics